Literature DB >> 34331269

Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview.

Jesús García-Foncillas1,2, Jesús Argente3,4, Luis Bujanda5, Victoria Cardona6,7, Bonaventura Casanova8,9, Ana Fernández-Montes10, José A Horcajadas11, Andrés Iñiguez12, Alberto Ortiz13, José L Pablos14,15, María Vanessa Pérez Gómez13.   

Abstract

Although the concept of precision medicine, in which healthcare is tailored to the molecular and clinical characteristics of each individual, is not new, its implementation in clinical practice has been heterogenous. In some medical specialties, precision medicine has gone from being just a promise to a reality that achieves better patient outcomes. This is a fact if we consider, for example, the great advances made in the genetic diagnosis and subsequent treatment of countless hereditary diseases, such as cystic fibrosis, which have improved the life expectancy of many of the affected children. In the field of oncology, the development of targeted therapies has prolonged the survival of patients with breast, lung, colorectal, melanoma, and hematological malignancies. In other disciplines, clinical milestones are perhaps less well known, but no less important. The current challenge is to expand and generalize the use of technologies that are central to precision medicine, such as massively parallel sequencing, to improve the management (prevention and treatment) of complex conditions such as cardiovascular, kidney, or autoimmune diseases. This process requires investment in specialized expertise, multidisciplinary collaboration, and the nationwide organization of genetic laboratories for diagnosis of specific diseases.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 34331269     DOI: 10.1007/s40291-021-00544-4

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  108 in total

Review 1.  Biomarkers in heart failure: the past, current and future.

Authors:  Michael Sarhene; Yili Wang; Jing Wei; Yuting Huang; Min Li; Lan Li; Enoch Acheampong; Zhou Zhengcan; Qin Xiaoyan; Xu Yunsheng; Mao Jingyuan; Gao Xiumei; Fan Guanwei
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

2.  Genomic medicine: time for health-care transformation.

Authors:  Richard H Scott; Tom A Fowler; Mark Caulfield
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

3.  Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).

Authors:  F Ciardiello; D Arnold; P G Casali; A Cervantes; J-Y Douillard; A Eggermont; A Eniu; K McGregor; S Peters; M Piccart; R Popescu; E Van Cutsem; C Zielinski; R Stahel
Journal:  Ann Oncol       Date:  2014-06-20       Impact factor: 32.976

4.  Getting Pharmacogenomics Into the Clinic.

Authors:  Jennifer Abbasi
Journal:  JAMA       Date:  2016-10-18       Impact factor: 56.272

Review 5.  Pharmacogenomic biomarkers for personalized cancer treatment.

Authors:  C Rodríguez-Antona; M Taron
Journal:  J Intern Med       Date:  2015-02       Impact factor: 8.989

Review 6.  Individualized Medicine in Gastroenterology and Hepatology.

Authors:  Michael C Stephens; Lisa A Boardman; Konstantinos N Lazaridis
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

7.  Personalized health care as a pathway for the adoption of genomic medicine.

Authors:  Robin Burnette; Leigh Ann Simmons; Ralph Snyderman
Journal:  J Pers Med       Date:  2012-11-13

8.  Conceptual and terminological confusion around personalised medicine: a coping strategy.

Authors:  Giovanni De Grandis; Vidar Halgunset
Journal:  BMC Med Ethics       Date:  2016-07-18       Impact factor: 2.652

Review 9.  Implementing genomic medicine in the clinic: the future is here.

Authors:  Teri A Manolio; Rex L Chisholm; Brad Ozenberger; Dan M Roden; Marc S Williams; Richard Wilson; David Bick; Erwin P Bottinger; Murray H Brilliant; Charis Eng; Kelly A Frazer; Bruce Korf; David H Ledbetter; James R Lupski; Clay Marsh; David Mrazek; Michael F Murray; Peter H O'Donnell; Daniel J Rader; Mary V Relling; Alan R Shuldiner; David Valle; Richard Weinshilboum; Eric D Green; Geoffrey S Ginsburg
Journal:  Genet Med       Date:  2013-01-10       Impact factor: 8.822

10.  Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.

Authors:  P Garrido; A Aldaz; R Vera; M A Calleja; E de Álava; M Martín; X Matías-Guiu; J Palacios
Journal:  Clin Transl Oncol       Date:  2017-08-31       Impact factor: 3.405

View more
  2 in total

1.  Edgar Morin, the complex thought and medicine.

Authors:  M Marvisi
Journal:  Ethics Med Public Health       Date:  2022-02-11

2.  A Window of Opportunity for Newborn Screening.

Authors:  Donald B Bailey
Journal:  Mol Diagn Ther       Date:  2022-05-04       Impact factor: 4.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.